<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Iqvia Holdings Inc — News on 6ix</title>
<link>https://6ix.com/company/iqvia-holdings-inc</link>
<description>Latest news and press releases for Iqvia Holdings Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 15 Apr 2026 20:15:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/iqvia-holdings-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683584c278dffbe2df0fd3cb.webp</url>
<title>Iqvia Holdings Inc</title>
<link>https://6ix.com/company/iqvia-holdings-inc</link>
</image>
<item>
<title>IQVIA to Announce First-Quarter 2026 Results on May 5, 2026</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-to-announce-first-quarter-2026-results-on-may-5-2026</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-to-announce-first-quarter-2026-results-on-may-5-2026</guid>
<pubDate>Wed, 15 Apr 2026 20:15:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., April 15, 2026--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its first-quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time that same day. The earnings release and accompanying finan</description>
</item>
<item>
<title>IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-unveils-iqviaai-a-unified-agentic-ai-platform-powered-by-nvidia-to-improve-efficiency-and-decision-making-across-life-sciences</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-unveils-iqviaai-a-unified-agentic-ai-platform-powered-by-nvidia-to-improve-efficiency-and-decision-making-across-life-sciences</guid>
<pubDate>Mon, 16 Mar 2026 20:30:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., March 16, 2026--IQVIA Holdings Inc. (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced at NVIDIA GTC the launch of IQVIA.ai, a unified agentic AI platform purpose-built to help life sciences organizations transform how they operate, make decisions and innovate across clinical, commercial and real-world domains.</description>
</item>
<item>
<title>IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-cfo-to-speak-at-barclays-28th-annual-global-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-cfo-to-speak-at-barclays-28th-annual-global-healthcare-conference</guid>
<pubDate>Mon, 02 Mar 2026 21:30:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., March 02, 2026--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Mike Fedock, executive vice president and chief financial officer, will speak at the Barclays 28th Annual Global Healthcare Conference on Thursday, March 12, 2026, at 9:30 a.m. ET.</description>
</item>
<item>
<title>IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-ceo-to-speak-at-leerink-partners-2026-global-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-ceo-to-speak-at-leerink-partners-2026-global-healthcare-conference</guid>
<pubDate>Mon, 02 Mar 2026 21:15:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., March 02, 2026--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Leerink Partners 2026 Global Healthcare Conference on Monday, March 9, 2026, at 9:20 a.m. ET.</description>
</item>
<item>
<title>IQVIA Releases its 2025 Sustainability Report</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-releases-its-2025-sustainability-report</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-releases-its-2025-sustainability-report</guid>
<pubDate>Fri, 27 Feb 2026 21:47:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., February 27, 2026--IQVIA Holdings Inc. (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today published its 2025 Sustainability Report. The report highlights IQVIA’s progress across its People, Public and Planet pillars, consistent with the company’s mission to accelerate innovation for a healthier world.</description>
</item>
<item>
<title>IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-signs-agreement-to-acquire-drug-discovery-assets-from-charles-river-laboratories-expanding-end-to-end-drug-discovery-capabilities-1</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-signs-agreement-to-acquire-drug-discovery-assets-from-charles-river-laboratories-expanding-end-to-end-drug-discovery-capabilities-1</guid>
<pubDate>Wed, 25 Feb 2026 12:00:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., February 25, 2026--IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories.</description>
</item>
<item>
<title>IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-to-speak-at-citis-2026-unplugged-medtech-and-life-sciences-access-day</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-to-speak-at-citis-2026-unplugged-medtech-and-life-sciences-access-day</guid>
<pubDate>Wed, 18 Feb 2026 21:15:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., February 18, 2026--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Ron Bruehlman, chief financial officer, and Mike Fedock, senior vice president, financial planning & analysis and incoming CFO, will speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day on Thursday, February 26, 2026, at</description>
</item>
<item>
<title>IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-duke-clinical-research-institute-130000067</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-duke-clinical-research-institute-130000067</guid>
<pubDate>Tue, 10 Feb 2026 13:00:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., February 10, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, and the Duke Clinical Research Institute (DCRI), one of the world’s largest academic clinical research organizations with extensive experience designing and operationally executing large, complex multi-center clinical trials, are pleased to announce their new collaboration to enh</description>
</item>
<item>
<title>IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-boehringer-ingelheim-announce-strategic-130000709</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-boehringer-ingelheim-announce-strategic-130000709</guid>
<pubDate>Thu, 29 Jan 2026 13:00:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., January 29, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic long-term collaboration with Boehringer Ingelheim. Boehringer Ingelheim has selected IQVIA’s Data-as-a-Service (DaaS+) technology offering as the accelerator to power its global commercial data harmonization and transformation journey.</description>
</item>
<item>
<title>IQVIA Named to the Fortune® World’s Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-named-fortune-world-most-210500371</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-named-fortune-world-most-210500371</guid>
<pubDate>Thu, 22 Jan 2026 21:05:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., January 22, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2026 Fortune® World’s Most Admired Companies™ list.</description>
</item>
<item>
<title>IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-announce-fourth-quarter-full-214500729</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-announce-fourth-quarter-full-214500729</guid>
<pubDate>Tue, 20 Jan 2026 21:45:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., January 20, 2026--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its fourth-quarter and full-year 2025 financial results before the market opens on Thursday, February 5, 2026. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time that same day. The earnings release</description>
</item>
<item>
<title>IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-announces-strategic-collaboration-aws-130000610</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-announces-strategic-collaboration-aws-130000610</guid>
<pubDate>Tue, 02 Dec 2025 13:00:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., December 02, 2025--IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic collaboration with Amazon Web Services (AWS), naming AWS as IQVIA’s Preferred Agentic Cloud Provider. The partnership, revealed at AWS re:Invent, is a major step in the digital transformation of healthcare and life sciences, aiming to revolutionize cl</description>
</item>
<item>
<title>Dr. William G. Kaelin Jr. joins IQVIA Board of Directors</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/dr-william-g-kaelin-jr-211500150</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/dr-william-g-kaelin-jr-211500150</guid>
<pubDate>Wed, 05 Nov 2025 21:15:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., November 05, 2025--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced the appointment of Dr. William G. Kaelin Jr. to its board of directors, effective today.</description>
</item>
<item>
<title>IQVIA Reports Third-Quarter 2025 Results</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-reports-third-quarter-2025-110000222</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-reports-third-quarter-2025-110000222</guid>
<pubDate>Tue, 28 Oct 2025 11:00:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., October 28, 2025--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2025.</description>
</item>
<item>
<title>IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-ceo-ari-bousbib-speak-201500832</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-ceo-ari-bousbib-speak-201500832</guid>
<pubDate>Tue, 21 Oct 2025 20:15:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., October 21, 2025--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Ari Bousbib, chairman and chief executive officer, will speak at the UBS Global Healthcare Conference on Tuesday, November 11, 2025 at 12:30 p.m. ET.</description>
</item>
<item>
<title>IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-announce-third-quarter-2025-201500711</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-announce-third-quarter-2025-201500711</guid>
<pubDate>Tue, 30 Sep 2025 20:15:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., September 30, 2025--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its third-quarter 2025 financial results before the market opens on Tuesday, October 28, 2025. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accomp</description>
</item>
<item>
<title>IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-receives-wcg-pinnacle-award-120000957</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-receives-wcg-pinnacle-award-120000957</guid>
<pubDate>Tue, 16 Sep 2025 12:00:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., September 16, 2025--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has been honored with the WCG Pinnacle Award for Site Relationships in Professionalism and Communication. The award recognizes IQVIA’s commitment to building strong, collaborative partnerships with clinical trial sites worldwide.</description>
</item>
<item>
<title>IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-announces-launch-clinical-trial-120000409</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-announces-launch-clinical-trial-120000409</guid>
<pubDate>Wed, 10 Sep 2025 12:00:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., September 10, 2025--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced the launch of its Clinical Trial Financial Suite (CTFS), an AI-enabled platform orchestrating all financial aspects of clinical trials. CTFS is designed to eliminate inefficiencies created by siloed systems and fragmented processes. In contrast to other industry</description>
</item>
<item>
<title>IQVIA Announces CFO Transition in Early 2026</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-announces-cfo-transition-early-130000884</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-announces-cfo-transition-early-130000884</guid>
<pubDate>Tue, 02 Sep 2025 13:00:00 GMT</pubDate>
<description>RESEARCH TRIANGLE PARK, N.C., September 02, 2025--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences and healthcare industries, today announced a planned leadership transition in its finance organization. Michael Fedock, currently Senior Vice President of Financial Planning & Analysis, has been appointed Executive Vice President and Chief Financial Officer, effective February 28, 202</description>
</item>
<item>
<title>IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies</title>
<link>https://6ix.com/company/iqvia-holdings-inc/news/iqvia-flagship-pioneering-announce-strategic-120000410</link>
<guid isPermaLink="true">https://6ix.com/company/iqvia-holdings-inc/news/iqvia-flagship-pioneering-announce-strategic-120000410</guid>
<pubDate>Thu, 28 Aug 2025 12:00:00 GMT</pubDate>
<description>IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, and Flagship Pioneering, the bioplatform innovation company, today announced a strategic collaboration to accelerate the development of breakthrough life sciences companies. The collaboration will help the Flagship ecosystem of biopharma companies accelerate innovation by offering access to IQVIA's comprehensive capabilities including unparalleled information assets, analy</description>
</item>
</channel>
</rss>